{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:01:05Z","timestamp":1780592465018,"version":"3.54.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13555-026-01759-1","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T12:19:24Z","timestamp":1776514764000},"page":"2947-2963","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidisciplinary Management in Psoriasis: A Structured Approach for Early Comorbidity Detection and Referral"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2121-963X","authenticated-orcid":false,"given":"Anna","family":"L\u00f3pez-Ferrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8060-4784","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Gonz\u00e1lez-Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5460-4139","authenticated-orcid":false,"given":"Ana","family":"Guti\u00e9rrez-Casbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1378-1590","authenticated-orcid":false,"given":"Antonio","family":"Martorell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2991-4688","authenticated-orcid":false,"given":"Antonio","family":"Olveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6218-8171","authenticated-orcid":false,"given":"Mar\u00eda Blanca","family":"Madrid-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7819-0471","authenticated-orcid":false,"given":"Joana","family":"Nicolau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4266-0771","authenticated-orcid":false,"given":"Jose Manuel","family":"Carrascosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8183-3941","authenticated-orcid":false,"given":"Ofelia","family":"Baniandr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4604-0724","authenticated-orcid":false,"given":"Raquel","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Ruiz-Villaverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8418-7145","authenticated-orcid":false,"given":"Rub\u00e9n","family":"Queiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4807-3551","authenticated-orcid":false,"given":"Pablo","family":"de la Cueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"5","key":"1759_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ad.2013.12.008","volume":"105","author":"C Ferr\u00e1ndiz","year":"2014","unstructured":"Ferr\u00e1ndiz C, Carrascosa JM, Toro M. Prevalence of psoriasis in Spain in the age of biologics. Actas Dermosifiliogr. 2014;105(5):504\u20139.","journal-title":"Actas Dermosifiliogr"},{"issue":"1","key":"1759_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1590\/abd1806-4841.20175178","volume":"92","author":"D Mil\u010di\u0107","year":"2017","unstructured":"Mil\u010di\u0107 D, Jankovi\u0107 S, Vesi\u0107 S, Milinkovi\u0107 M, Marinkovi\u0107 J, \u0106irkovi\u0107 A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study. An Bras Dermatol. 2017;92(1):46\u201351.","journal-title":"An Bras Dermatol"},{"issue":"4","key":"1759_CR3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","volume":"80","author":"CA Elmets","year":"2019","unstructured":"Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019;80(4):1073\u2013113.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1759_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.medcli.2024.08.019","volume":"164","author":"L Cayuela","year":"2025","unstructured":"Cayuela L, Pereyra-Rodr\u00edguez JJ, Hern\u00e1ndez-Rodr\u00edguez JC, Rodr\u00edguez Fernandez-Freire L, Cayuela A. Increasing prevalence of psoriasis in Spain: a population-based study (2018-2022). Med Clin (Barc). 2025;164(3):117\u201322.","journal-title":"Med Clin (Barc)"},{"issue":"Suppl 2","key":"1759_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jdv.13542","volume":"30","author":"E Dauden","year":"2016","unstructured":"Dauden E, Puig L, Ferrandiz C, Sanchez-Carazo JL, Hernanz-Hermosa JM, Spanish Psoriasis Group of the Spanish Academy of D. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology. J Eur Acad Dermatol Venereol. 2016;30(Suppl 2):1\u201318.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9583","key":"1759_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263\u201371.","journal-title":"Lancet"},{"issue":"1","key":"1759_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24872-5","volume":"12","author":"Y Sun","year":"2022","unstructured":"Sun Y, Li Y, Zhang J. The causal relationship between psoriasis, psoriatic arthritis, and inflammatory bowel diseases. Sci Rep. 2022;12(1):20526.","journal-title":"Sci Rep"},{"issue":"5","key":"1759_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3899\/jrheum.140474","volume":"42","author":"R Ranza","year":"2015","unstructured":"Ranza R, Carneiro S, Qureshi AA, Martins G, Rodrigues JJ, Romiti R, et al. Prevalence of psoriatic arthritis in a large cohort of Brazilian patients with psoriasis. J Rheumatol. 2015;42(5):829\u201334.","journal-title":"J Rheumatol"},{"issue":"12","key":"1759_CR9","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/jamadermatol.2018.3631","volume":"154","author":"Y Fu","year":"2018","unstructured":"Fu Y, Lee CH, Chi CC. Association of psoriasis with inflammatory bowel disease: a systematic review and meta-analysis. JAMA Dermatol. 2018;154(12):1417\u201323.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"1759_CR10","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.jhep.2009.04.020","volume":"51","author":"P Gisondi","year":"2009","unstructured":"Gisondi P, Targher G, Zoppini G, Girolomoni G. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009;51(4):758\u201364.","journal-title":"J Hepatol"},{"issue":"4","key":"1759_CR11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jhep.2009.06.008","volume":"51","author":"L Miele","year":"2009","unstructured":"Miele L, Vallone S, Cefalo C, La Torre G, Di Stasi C, Vecchio FM, et al. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009;51(4):778\u201386.","journal-title":"J Hepatol"},{"issue":"7","key":"1759_CR12","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/ced.12672","volume":"40","author":"R Abedini","year":"2015","unstructured":"Abedini R, Salehi M, Lajevardi V, Beygi S. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease. Clin Exp Dermatol. 2015;40(7):722\u20137.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"1759_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.adengl.2018.05.035","volume":"110","author":"S Gonz\u00e1lez-Parra","year":"2019","unstructured":"Gonz\u00e1lez-Parra S, Daud\u00e9n E. Psoriasis and depression: the role of inflammation. Actas Dermo-Sifiliogr\u00e1ficas (English Edition). 2019;110(1):12\u20139.","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"},{"issue":"1\u20133","key":"1759_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jad.2009.04.016","volume":"120","author":"A Gabilondo","year":"2010","unstructured":"Gabilondo A, Rojas-Farreras S, Vilagut G, Haro JM, Fern\u00e1ndez A, Pinto-Meza A, et al. Epidemiology of major depressive episode in a southern European country: results from the ESEMeD-Spain project. J Affect Disord. 2010;120(1\u20133):76\u201385.","journal-title":"J Affect Disord"},{"issue":"12","key":"1759_CR15","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/ced\/llae282","volume":"49","author":"LMH Arancio","year":"2024","unstructured":"Arancio LMH, D\u2019Amico D, Dastoli S, Fiorella CS, Manfredini M, Moretta G, et al. Early intervention and cumulative life course impairment in psoriasis: a review. Clin Exp Dermatol 2024;49(12):1525\u201331.","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"1759_CR16","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.ad.2020.06.004","volume":"111","author":"I Belinch\u00f3n","year":"2020","unstructured":"Belinch\u00f3n I, Salgado-Boquete L, L\u00f3pez-Ferrer A, Ferran M, Coto-Segura P, Rivera R, et al. Dermatologists\u2019 role in the early diagnosis of psoriatic arthritis: expert recommendations. Actas Dermosifiliogr (Engl Ed). 2020;111(10):835\u201346.","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"issue":"4","key":"1759_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/jvc2.63","volume":"1","author":"H Ben Abdallah","year":"2022","unstructured":"Ben Abdallah H, Emmanuel T, Bregnh\u00f8j A, Johansen C, Iversen L. Early intervention and disease memory in psoriasis: a literature review. JEADV Clin Pract. 2022;1(4):307\u201316.","journal-title":"JEADV Clin Pract"},{"issue":"20","key":"1759_CR18","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.3390\/diagnostics13203183","volume":"13","author":"L Cantoro","year":"2023","unstructured":"Cantoro L, Monterubbianesi R, Falasco G, Camastra C, Pantanella P, Allocca M, et al. The earlier you find, the better you treat: red flags for early diagnosis of inflammatory bowel disease. Diagnostics (Basel). 2023;13(20):3183.","journal-title":"Diagnostics (Basel)"},{"key":"1759_CR19","doi-asserted-by":"publisher","first-page":"1027347","DOI":"10.3389\/fmed.2022.1027347","volume":"9","author":"PAO Felix","year":"2022","unstructured":"Felix PAO, Sampaio AL, Silva BL, Viana ALP. Early intervention in psoriasis: Where do we go from here? Frontiers in Medicine. 2022;9:1027347.","journal-title":"Front Med"},{"issue":"4","key":"1759_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ad.2015.09.015","volume":"107","author":"J Garc\u00eda-Campayo","year":"2016","unstructured":"Garc\u00eda-Campayo J, P\u00e9rez-Yus MC, Garc\u00eda-Bustinduy M, Daud\u00e9n E. Early detection of emotional and behavioral disorders in dermatology. Actas Dermosifiliogr. 2016;107(4):294\u2013300.","journal-title":"Actas Dermosifiliogr"},{"issue":"6","key":"1759_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6\u2005months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74(6):1045\u201350.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1759_CR22","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1111\/jdv.15177","volume":"32","author":"E Dauden","year":"2018","unstructured":"Dauden E, Blasco AJ, Bonanad C, Botella R, Carrascosa JM, Gonz\u00e1lez-Parra E, et al. Position statement for the management of comorbidities in psoriasis. J Eur Acad Dermatol Venereol. 2018;32(12):2058\u201373.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"1759_CR23","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/jdv.12024","volume":"27","author":"E Daud\u00e9n","year":"2013","unstructured":"Daud\u00e9n E, Casta\u00f1eda S, Su\u00e1rez C, Garc\u00eda-Campayo J, Blasco AJ, Aguilar MD, et al. Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. J Eur Acad Dermatol Venereol. 2013;27(11):1387\u2013404.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"1759_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ad.2022.01.024","volume":"113","author":"JM Carrascosa","year":"2022","unstructured":"Carrascosa JM, Puig L, Romero IB, Salgado-Boquete L, del Alc\u00e1zar E, Lencina JJA, et al. Actualizaci\u00f3n pr\u00e1ctica de las recomendaciones del Grupo de Psoriasis de la Academia Espa\u00f1ola de Dermatolog\u00eda y Venereolog\u00eda (GPS) para el tratamiento de la psoriasis con terapia biol\u00f3gica. Parte 2 \u00abManejo de poblaciones especiales, pacientes con comorbilidad y gesti\u00f3n del riesgo\u00bb. Actas Dermosifiliogr. 2022;113(6):583\u2013609.","journal-title":"Actas Dermosifiliogr"},{"key":"1759_CR25","first-page":"1","volume":"103","author":"E Daud\u00e9n","year":"2012","unstructured":"Daud\u00e9n E, Casta\u00f1eda S, Su\u00e1rez C, Garc\u00eda-Campayo J, Blasco AJ, Aguilar MD, et al. Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities. Actas Dermosifiliogr. 2012;103:1\u201364.","journal-title":"Actas Dermosifiliogr"},{"issue":"5","key":"1759_CR26","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1046\/j.1365-2648.1996.09623.x","volume":"23","author":"O Carney","year":"1996","unstructured":"Carney O, McIntosh J, Worth A. The use of the nominal group technique in research with community nurses. J Adv Nurs. 1996;23(5):1024\u20139.","journal-title":"J Adv Nurs"},{"issue":"6","key":"1759_CR27","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"issue":"2","key":"1759_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518\u201326.","journal-title":"Hepatology"},{"issue":"1","key":"1759_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.gastrohep.2017.03.012","volume":"41","author":"J Sanz Sanz","year":"2018","unstructured":"Sanz Sanz J, Juanola Roura X, Seoane-Mato D, Montoro M, Gomoll\u00f3n F. Criterios de cribado de enfermedad inflamatoria intestinal y espondiloartritis para derivaci\u00f3n de pacientes entre Reumatolog\u00eda y Gastroenterolog\u00eda. Gastroenterol Hepatol. 2018;41(1):54\u201362.","journal-title":"Gastroenterol Hepatol"},{"key":"1759_CR30","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143\u2013421.","DOI":"10.1161\/circ.106.25.3143"},{"issue":"11","key":"1759_CR31","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1111\/jdv.14861","volume":"32","author":"E Audureau","year":"2018","unstructured":"Audureau E, Roux F, Lons Danic D, Bagot M, Cantagrel A, Dernis E, et al. Psoriatic arthritis screening by the dermatologist: development and first validation of the \u201cPURE-4 scale.\u201d J Eur Acad Dermatol Venereol. 2018;32(11):1950\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"1759_CR32","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ad.2020.03.004","volume":"111","author":"I Belinch\u00f3n","year":"2020","unstructured":"Belinch\u00f3n I, Queiro R, Salgado-Boquete L, L\u00f3pez-Ferrer A, Ferran M, Coto-Segura P, et al. Linguistic and cultural adaptation to Spanish of the screening tool psoriatic arthritis UnclutteRed screening evaluation (PURE4). Actas Dermosifiliogr (Engl Ed). 2020;111(8):655\u201364.","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"issue":"6","key":"1759_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"1759_CR34","first-page":"345","volume":"12","author":"C Mont\u00f3n","year":"1993","unstructured":"Mont\u00f3n C, P\u00e9rez Echeverr\u00eda MJ, Campos R, Garc\u00eda Campayo J, Lobo A. [Anxiety scales and Goldberg\u2019s depression: an efficient interview guide for the detection of psychologic distress]. Aten Primaria. 1993;12(6):345\u20139.","journal-title":"Aten Primaria"},{"issue":"12","key":"1759_CR35","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","volume":"168","author":"K Posner","year":"2011","unstructured":"Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266\u201377.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1759_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ad.2021.10.003","volume":"113","author":"JM Carrascosa","year":"2022","unstructured":"Carrascosa JM, Puig L, Belinch\u00f3n Romero I, Salgado-Boquete L, del Alc\u00e1zar E, Andr\u00e9s Lencina JJ, et al. Actualizaci\u00f3n pr\u00e1ctica de las recomendaciones del Grupo de Psoriasis de la Academia Espa\u00f1ola de Dermatolog\u00eda y Venereolog\u00eda (GPS) para el tratamiento de la psoriasis con terapia biol\u00f3gica. Parte 1. \u00abConceptos y manejo general de la psoriasis con terapia biol\u00f3gica\u00bb. Actas Dermosifiliogr. 2022;113(3):261\u201377.","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"1759_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/jdv.16926","volume":"35","author":"A Nast","year":"2021","unstructured":"Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Cs\u00f6rg\u00f6 Z, Boonen H, et al. EuroGuiDerm guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations. J Eur Acad Dermatol Venereol. 2021;35(2):281\u2013317.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"1759_CR38","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","volume":"143","author":"JM Gelfand","year":"2007","unstructured":"Gelfand JM, Troxel AB, Lewis JD, Kurd SK, Shin DB, Wang X, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol. 2007;143(12):1493\u20139.","journal-title":"Arch Dermatol"},{"issue":"4","key":"1759_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","volume":"41","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Weiss P. The epidemiology of psoriatic arthritis. Rheum Dis Clin North Am. 2015;41(4):545\u201368.","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"1759_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/annrheumdis-2012-201972","volume":"73","author":"E Theander","year":"2014","unstructured":"Theander E, Husmark T, Alenius GM, Larsson PT, Teleman A, Geijer M, et al. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA). Ann Rheum Dis. 2014;73(2):407\u201313.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1759_CR41","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1136\/ard.2011.150938","volume":"70","author":"DD Gladman","year":"2011","unstructured":"Gladman DD, Thavaneswaran A, Chandran V, Cook RJ. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Ann Rheum Dis. 2011;70(12):2152\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1759_CR42","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","volume":"69","author":"PJ Mease","year":"2013","unstructured":"Mease PJ, Gladman DD, Papp KA, Khraishi MM, Tha\u00e7i D, Behrens F, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729\u201335.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1759_CR43","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2012-201706","volume":"72","author":"M Haroon","year":"2013","unstructured":"Haroon M, Kirby B, FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis. 2013;72(5):736\u201340.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1759_CR44","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1365-2133.2008.09023.x","volume":"160","author":"K Reich","year":"2009","unstructured":"Reich K, Kr\u00fcger K, M\u00f6ssner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160(5):1040\u20137.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1759_CR45","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"1759_CR46","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/jdv.12350","volume":"28","author":"R Strohal","year":"2014","unstructured":"Strohal R, Kirby B, Puig L, Girolomoni G, Kragballe K, Luger T, et al. Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol. 2014;28(12):1661\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"1759_CR47","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825\u201330.","journal-title":"Ann Intern Med"},{"key":"1759_CR48","unstructured":"Sanz Sanz J, Juanola Roura X, Seoane-Mato D, Montoro M, Gomoll\u00f3n F. Screening of inflammatory bowel disease and spondyloarthritis for referring patients between rheumatology and gastroenterology. (0210\u20135705 (Print))."},{"issue":"3","key":"1759_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2024.502255","volume":"48","author":"D Ginard","year":"2025","unstructured":"Ginard D, Fontanillas N, Bast\u00f3n-Rey I, Pejenaute ME, Piqueras M, Alcalde S, et al. Documento de posicionamiento de la Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN) y del Grupo Espa\u00f1ol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el manejo de la enfermedad inflamatoria intestinal en atenci\u00f3n primaria. Gastroenterol Hepatol. 2025;48(3):502255.","journal-title":"Gastroenterol Hepatol"},{"issue":"3 Pt 1","key":"1759_CR50","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/jid.2011.365","volume":"132","author":"SM Langan","year":"2012","unstructured":"Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol. 2012;132(3 Pt 1):556\u201362.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"1759_CR51","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","volume":"55","author":"AL Neimann","year":"2006","unstructured":"Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829\u201335.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1759_CR52","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3109\/09546634.2014.983039","volume":"26","author":"I Belinch\u00f3n","year":"2015","unstructured":"Belinch\u00f3n I, Vanaclocha F, de la Cueva-Dobao P, Coto-Segura P, Labandeira J, Herranz P, et al. Metabolic syndrome in Spanish patients with psoriasis needing systemic therapy: prevalence and association with cardiovascular disease in PSO-RISK, a cross-sectional study. J Dermatolog Treat. 2015;26(4):318\u201325.","journal-title":"J Dermatolog Treat"},{"key":"1759_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-026-01664-7","author":"J Nicolau","year":"2026","unstructured":"Nicolau J, L\u00f3pez-Ferrer A, de la Cueva P. Management of obesity in psoriasis consultations. Dermatol Ther (Heidelb). 2026. https:\/\/doi.org\/10.1007\/s13555-026-01664-7.","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01759-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01759-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01759-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:02:16Z","timestamp":1780588936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01759-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1759"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01759-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Jos\u00e9 Manuel Carrascosa has served as principal investigator, scientific investigator, invited speaker, advisor and\/or member of steering committees for Gebro, Nordic Pharma, Leo Pharma, AbbVie, Janssen, Novartis, Almirall, UCB, Lilly, Sandoz, Boehringer Ingelheim, Pfizer, Galderma and Bristol Myers Squibb, receiving grants and\/or other compensation. Dr Jos\u00e9 Manuel Carrascosa is an Editorial Board member of Dermatology and Therapy. Dr Jos\u00e9 Manuel Carrascosa was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Dr \u00c1lvaro Gonz\u00e1lez-Cantero has served as a consultant for AbbVie, Apogee, Innovaderm, Organon, Janssen, Novartis, Lilly, Bristol Myers Squibb, Almirall, Boehringer Ingelheim, Amgen, Cerave, L'Or\u00e9al, Celgene and Leo Pharma, receiving grants and\/or other compensation. Dr Ana Guti\u00e9rrez has received research support, congress sponsorship and\/or personal fees as a speaker or consultant from AbbVie, Janssen, Lilly, FAES, Ferring, Adacyte, Takeda, Pfizer, Gal\u00e1pagos, Sandoz, Alfasigma, Falk and Fresenius Kabi. Dr Anna L\u00f3pez Ferrer has received institutional research support, consultancy fees, and speaker honoraria from AbbVie, Almirall, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, J&J Innovative Medicine, Leo Pharma, Lilly, Novartis, Takeda and UCB. Dr Anna L\u00f3pez Ferrer is an Editorial Board member of\n                      Dermatology and Therapy\n                      . Dr Anna L\u00f3pez Ferrer was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Dr Antonio Martorell has received institutional research support, consultancy fees, and speaker honoraria from AbbVie, Almirall, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, J&J Innovative Medicine, Leo Pharma, Lilly, Novartis, Incyte, Sanofi, Pfizer and UCB. Dr Antonio Olveira has provided advisory services for Madrigal, Novartis, Amgen and Boehringer, and has given presentations for Novo Nordisk and Novartis. Dr Ofelia Baniandr\u00e9s has participated as a consultant or speaker in events sponsored by J&J Innovative Medicine, AbbVie, Novartis, Lilly, Leo Pharma, Amgen, Boehringer Ingelheim, UCB, Bristol Myers Squibb and Almirall. Dr Pablo de la Cueva has acted as an advisor, investigator and\/or speaker for the following pharmaceutical companies: AbbVie, Almirall, Astellas, Biogen, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, Gebro, Janssen, Leo Pharma, Lilly, MSD, Novartis, Pfizer, Sandoz, Sanofi and UCB. Dr Raquel Rivera has served as an advisor, speaker and investigator, and has received congress support from AbbVie, Almirall, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Incyte, Janssen, Leo Pharma, Lilly, Novartis, Takeda and UCB. Dr Rub\u00e9n Queiro has received institutional research support, project development funding, consultancy fees and speaker honoraria from AbbVie, Almirall, Amgen, J&J Innovative Medicine, Lilly, Novartis, Pfizer and UCB. The remaining authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}